Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 1:55 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 489 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Ophthalmic Surgery Clear all

Conditions: Epiretinal Membrane
Interventions: Immediate Vitrectomy, Deferred Vitrectomy; Procedure
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 45 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 48
States / cities: Scottsdale, Arizona • Glendale, California • Huntington Beach, California + 41 more

Conditions: Cataract
Interventions: ORA with VerifEye+, Alcon Barrett Toric Calculator, Acrysof® IQ Toric IOL; Device · Other
Lead sponsor: Alcon Research; Industry
Eligibility: 22 Years and older
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 9
States / cities: Mt. Dora, Florida • Panama City, Florida • Poughkeepsie, New York + 6 more

Conditions: Pars Plana Vitrectomy, Scleral Buckling, Surgical Outcomes, Infection Prophylaxis
Interventions: Not listed
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Cataract Extraction
Interventions: Moxifloxacin 0.5% ophthalmic solution, Besifloxacin 0.6% ophthalmic suspension; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 21 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Cataract
Interventions: Dexamethasone Phosphate Ophthalmic, 100 mM Sodium Citrate Buffer; Drug
Lead sponsor: Eyegate Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 3
States / cities: Miami, Florida • Tamarac, Florida • Washington, Missouri

Conditions: Ocular Surface Disease, Glaucoma, Open-Angle
Interventions: iStent or iStent inject implantation with concomitant cataract surgery; Device
Lead sponsor: Vance Thompson Vision; Other
Eligibility: 22 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Emergence Delirium, Strabismus
Interventions: Dexmedetomidine; Drug
Lead sponsor: Ochsner Health System; Other
Eligibility: Up to 18 Years
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Jefferson, Louisiana

Conditions: Open-Angle Glaucoma
Interventions: Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis; Procedure
Lead sponsor: Barnet Dulaney Perkins Eye Centers; Network
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Mesa, Arizona

Conditions: Surgery
Interventions: EEG Electrode Patch, Standard Needles; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Glaucoma
Interventions: KDB/Phacoemulsification, Trabectome/Phacoemulsification; Procedure
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years to 95 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Eye Manifestations
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 0 Years and older
Enrollment: 269 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2018
U.S. locations: 2
States / cities: Durham, North Carolina • Cleveland, Ohio

Conditions: Cataracts
Interventions: Manual Small Incision Cataract Surgery; Procedure
Lead sponsor: University of Arizona; Other
Eligibility: 21 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Cataract
Interventions: Dextenza 0.4Mg Ophthalmic Insert, Topical prednisolone acetate; Drug
Lead sponsor: Vance Thompson Vision; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Cataracts, Corneal Edema, Retinal Structural Change, Deposit and Degeneration, Visual Acuity Reduced Transiently
Interventions: Difluprednate ophthalmic emulsion 0.05%, Prednisolone acetate 1%; Drug
Lead sponsor: Edward J. Holland; Other
Eligibility: 21 Years and older
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 3
States / cities: Edgewood, Kentucky • Lynbrook, New York • Mt. Pleasant, South Carolina

Conditions: Glaucoma
Interventions: Collection of trabecular meshwork tissue during surgery; Other
Lead sponsor: Wills Eye; Other
Eligibility: 21 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Inflammation, Pain, Cataract
Interventions: XG-102, Placebo; Drug
Lead sponsor: Xigen SA; Industry
Eligibility: 18 Years and older
Enrollment: 339 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Garden Grove, California

Conditions: Glaucoma, Open-Angle
Interventions: OMNI® Surgical System, iStent inject; Device
Lead sponsor: Sight Sciences, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 2
States / cities: Dothan, Alabama • Vineland, New Jersey

Conditions: Cataract
Interventions: Standard of Care4; Device
Lead sponsor: Research Insight LLC; Industry
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Laguna Hills, California

Conditions: Myopia
Interventions: Photorefractive Keratectomy (PRK); Procedure
Lead sponsor: Walter Reed Army Medical Center; Federal
Eligibility: 21 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Glaucoma
Interventions: Pilocarpine, Prednisolone, Ofloxacin; Drug
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 30 Years to 100 Years
Enrollment: 142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 2
States / cities: The Bronx, New York

Conditions: Spine Surgery, Vision Impairment
Interventions: table tilt; Other
Lead sponsor: University of Medicine and Dentistry of New Jersey; Other
Eligibility: 18 Years to 65 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 2
States / cities: Newark, New Jersey

Conditions: Delirium
Interventions: eye masks and earplugs; Other
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cataract
Interventions: OMIDRIA (*Registered Product) {10.16 mg/mL (1% w/v) of phenylephrine and 2.88 mg/mL (0.3% w/v) of ketorolac}, Ketorolac Tromethamine {TORADOL} (0.5%) - Topical Eyedrop; Combination Product · Other
Lead sponsor: DHS Consulting; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Westbury, New York

Conditions: Glaucoma, Open-angle, Ocular Hypertension (OHT), Phacoemulsification Cataract Surgery
Interventions: iDose TR (travoprost intracameral implant) 75 µg in conjunction with cataract surgery, Sham procedure in conjunction with cataract surgery; Combination Product · Procedure
Lead sponsor: Glaukos Corporation; Industry
Eligibility: 45 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Kenosha, Wisconsin

Search by objective public record fields.

Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM

Postmarket Study of an Intraocular Lens Power Selection System

Necessity of Post-operative Eye Drops

Study of Ocular Penetration of Topically Administered Fluoroquinolones

Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Delivery Prior to Implantation of a Posterior Chamber IOL

Ocular Surface Disease Changes After iStent or iStent Inject Implantation With Phacoemulsification

KETODEX for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery

Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis

Intraoperative Non-invasive Eye Movement Monitoring

Effect of Intra-subject Phaco/Trabectome vs. Phaco/Kahook Dual Blade on Intraocular Pressure

Intraoperative OCT Guidance of Intraocular Surgery

Manual Small Incision Cataract Surgery Outcomes in an Educational Setting

In Clinic Optometrist Insertion of Dextenza Prior to Cataract Surgery

Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery.

The Changes Within the Cells of the Drainage System of the Eye in Patients With Glaucoma

Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation

A Post-market Study Of Use Of The OMNI® Surgical System In Open Angle Glaucoma

Veracity Surgical: A Time/Motion and Quality of Care Study

Evaluation of Conventional Photorefractive Keratectomy (PRK) in U.S. Army Personnel, Substudy of: Initial Evaluation of Excimer Laser Keratorefractive Surgery in U.S. Army Personnel

Pilocarpine Use After Kahook Goniotomy

Intraocular Pressure During Prone Spinal Surgery

Reducing Delirium in the Surgical Intensive Care Unit

Ketorolac Levels in Vitreous and Aqueous Samples From Patients Undergoing Combined Cataract and Pars Plana Vitrectomy Surgeries With and Without Intracameral Phenylephrine 1.0% / Ketorolac 0.3%

Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone